ArticlePoultry science2026
Host-derived Limosilactobacillus reuteri R30 and Cytobacillus solani Y5 improve growth performance and intestinal health of Danzhou chickens by regulating the jejunal microbiota.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intestinal health status is an important factor affecting of body weight (BW), and impaired growth performance is frequently associated with compromised intestinal barrier function. To address this issue, host‑derived probiotics were explored as an improvement strategy. Limosilactobacillus reuteri R30 (L. reuteri R30) and Cytobacillus solani Y5 (C. solani Y5) were isolated from the jejunal microbiota of high‑body‑weight (HBW) adult Danzhou hens. In a 42-day feeding trial, 200 one-day-old chicks were allocated to four groups: a control (CON) group receiving 1mL sterile medium by oral gavage; the treatment groups receiving the same volume of L. reuteri R30 (LR), C. solani Y5 (CS), and a 1:1 mixed bacterial suspension (LR-CS), each at 1.0 × 10⁹ CFU/mL every day. The results showed that chicks in the LR and LR‑CS groups had significantly higher BW than CON (P < 0.05). The LR group exhibited significantly increased glutathione peroxidase (GSH-Px) activity in serum, and the CS and LR-CS groups had significantly decreased levels of interleukin-6 (IL-6), IL-1β, and malondialdehyde (MDA) relative to CON (P < 0.05). Regarding intestinal morphology, significantly higher villus height (VH) and crypt depth (CD) were observed in both the ileum and jejunum of all probiotic groups. Notably, the LR group had a higher villus height‑to‑crypt depth ratio (V/C) than the CON (P < 0.05). In the LR group, both protein content and mRNA expression of Claudin‑1 in the jejunum were significantly greater, while ileal Occludin mRNA expression and protein content were increased in all probiotic groups (P < 0.05). Concerning jejunal inflammation and antioxidant status, the LR group exhibited significantly decreased IL‑6 levels, the LR‑CS group exhibited significantly reduced IL‑1β levels, and catalase (CAT) activity was significantly enhanced (P < 0.05). In all probiotic groups, the levels of MDA was decreased in the jejunum (P < 0.05). In addition, the abundance of Lactobacillus aviarius was significantly increased in the LR and LR-CS groups. In the LR group, metabolites such as β-hydroxychenodeoxycholic acid, 12-ketolithocholic acid, and hyocholic acid were positively correlated with the Clostridia and Clostridiaceae. Notably, these metabolites were significantly positively correlated with BW and serum GSH-Px activity, and significantly negatively correlated with serum IL-6 levels. These findings suggest that L. reuteri R30 and C. solani Y5 can promote growth and improve intestinal health, and these benefits were associated with alterations in the gut microbiota and host metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.